CMS Finalizes Rate Hike for BG Medicine's Galectin-3 Test | GenomeWeb

NEW YORK (GenomeWeb News) – BG Medicine said today that the Centers for Medicare and Medicaid Services have published the final determination of the 2014 Medicare national limitation amount for the company's galectin-3 test, arriving at a price of $30.01.

This is an increase over the test's 2013 national limitation of $17.80, and represents a win for BG Medicine, which had petitioned CMS for reconsideration of the 2013 determination.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.